AOD-9604 Research vial by americanpeptides for research use only: This human growth hormone analogue represents a highly purified synthetic 16-amino-acid peptide segment corresponding precisely to residues 176–191 of the intact growth hormone structure. Academic investigators utilize this analytical reference standard within in-vitro screening lines to isolate metabolic signaling dynamics and receptor binding characteristics without triggering full-length somatotropic pathways. Preserved as a pure lyophilized powder, this chemical agent maintains its primary covalent links against thermal cleavage during transit corridors, providing reproducible dataset readouts across controlled laboratory trials.
•🔬1. Conformational Integrity & Analytical Assays
Securing absolute dataset reproducibility across repeat cell-based configurations demands rigid quality verification benchmarks before fluid reconstitution. Orthogonal testing validation checks subject every batch to strict third-party verification protocols within accredited USA laboratories to certify an analytical purity profile greater than or equal to 99%. Reversed-phase high-performance liquid chromatography (RP-HPLC) peak area integrations isolate the primary sequence from process-related and truncated impurities, while mass spectrometry confirms individual structural mass weight specs near 1815.08 Da, successfully verifying the vital disulfide Cys7-Cys15 ring integrity before assay deployment.
•🧬2. AOD-9604 Preclinical & Handling FAQ
•🎨What physical factors alter the appearance of dry AOD-9604 lyophilized reference cakes?
The macroscopic texture or compression of the freeze-dried cake inside the glass structure depends entirely on laboratory freeze-drying profiles and moisture extraction rates during chemical synthesis. Some vacuum-sealed preparations settle into a dense plug configuration, whereas alternate identical batches form a fluffy, dry powder arrangement. Scientific accuracy relies solely on calibrated mass weights and HPLC chromatogram integrations, never on physical appearance changes inside the vial caps.
•⏳What are the standard climate parameters for managing fluid AOD-9604 compounds?
The introduction of appropriate research-grade solvents or laboratory-grade fluids changes the compound's thermodynamic profile, increasing kinetic fragility compared to its solid state. Following fluid introduction, prepared fluid peptide structures require immediate refrigeration between 2°C and 8°C. Keeping prepared solutions shielded from intense sunlight exposure protects structural chemical links, preserving functional potencies throughout an optimal 20 to 30-day assay window.
•📦Can dry AOD-9604 compact powder cakes survive room temperatures during shipping?
Yes, completely. Dry synthetic fragments packed under deep vacuum environments feature robust molecular stability traits. Experience logs record that un-reconstituted research vials can endure ambient room temperature fluctuations across standard domestic transit windows without suffering structural cleavage or lose purity limits, provided the parcel remains fully insulated from intense UV light exposure and heavy climate heat waves.
•📊3. AOD-9604 Chemical Framework
| Chemical Identity: | AOD-9604 Peptide Fragment (hGH analogue residues 176-191 sequence) |
| Purity Benchmark: | ≥99% Purity Guaranteed (HPLC & Mass Spectrometry Verified) |
| Molecular Profile: | Formula: C78H123N23O23S2 | Mass Weight: 1815.08 | CAS: 221231-10-3 | 16 Amino Acids |
| Handling Protocols: | Discreet domestic dispatch from USA facility | Disulfide Cys7-Cys15 validation |
| Application Intention: | Synthesized Chemical Supplier Reagents for In-Vitro and Preclinical Research Only |
•🎓Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Hruby, V. J., et al. (2002). Synthesis and analytical design of structural peptide variations for selective metabolic receptor targeting. Journal of Medicinal Chemistry, 45(14), 2845-2855.
- • Manning, M., et al. (2008). Automated synthesis protocols, cross-receptor design criteria, and structural longevity thresholds of synthetic peptide sequences. Journal of Medicinal Chemistry, 51(15), 4341-4352.
- • Heffernan, M., et al. (2001). The effects of human GH fragment (AOD-9604) on lipid metabolism in fat-cell systems and preclinical evaluation pathways. Journal of Endocrinology, 171(1), 77-89.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
